NCT05791370 (RPO) is a NA clinical trial of A 12-week parallel dietary intervention in Diet, sponsored by Malaysia Palm Oil Board.

Who is sponsoring NCT05791370?

NCT05791370 is sponsored by Malaysia Palm Oil Board.

What drugs are being tested in NCT05791370?

Interventions in NCT05791370: A 12-week parallel dietary intervention.

What condition does NCT05791370 study?

NCT05791370 studies Diet, Healthy.

Is NCT05791370 still recruiting?

NCT05791370 is currently completed. Last updated 30 March 2023.

Last reviewed 2023-03-30 · How we verify

NCT05791370: RPO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Red Palm Olein on Inflammation and Gut Health

Completed NA Last updated 30 March 2023

What this trial tests

NA trial testing A 12-week parallel dietary intervention in Diet in 156 participants. Completed in 30 November 2022.

Timeline

1 January 2019

Primary endpoint
30 May 2019

30 November 2022

Quick facts

Lead sponsor	Malaysia Palm Oil Board
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	156
Start date	1 January 2019
Primary completion	30 May 2019
Estimated completion	30 November 2022
Sites	1 location across Malaysia

Drugs / interventions tested

A 12-week parallel dietary intervention

Conditions studied

Diet — all drugs for Diet →
Healthy — all drugs for Healthy →

Sponsor

Malaysia Palm Oil Board

Who can join

Adults 20 to 50, any sex, with Diet or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A parallel intervention was conducted to test the effect of consuming diets enriched with red palm olein (RPOO), extra virgin coconut oil (EVCO) and extra virgin olive oil (EVOO; positive control) in centrally obese individuals over a 12-week period. Following the screening of the subjects' health status, including their biochemical and lipid profiles, the subjects completed a 12-week dietary intervention. Both fasting blood and urine samples were collected at baseline (day 0) and endpoint (week 12); measurements were taken in duplicates. All data collected were blinded to the investigators by an independent third party until the completion of the analysis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Effects of Tocotrienol on Gut Microbiota: A Scoping Review.
Kumareswaran A, Ekeuku SO, Mohamed N, Muhammad N, et al · · 2023 · cited 4× · PMID 37763286 · DOI 10.3390/life13091882
Diverse impacts of red palm olein, extra virgin coconut oil and extra virgin olive oil on cardiometabolic risk markers in individuals with central obesity: a randomised trial.
Teng KT, Loganathan R, Chew BH, Khang TF. · · 2024 · cited 1× · PMID 38372798 · DOI 10.1007/s00394-024-03338-6

Verify or expand the search:

Other recruiting trials for Diet

Currently open trials in the same condition.

NCT06848491 — Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors · NA · recruiting
NCT06955975 — The Effect of Pectin Supplementation on Geriatric With Frailty: A Randomised Placebo-Controlled Dietary Intervention Stu · NA · recruiting
NCT06735599 — Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure · NA · recruiting
NCT06753682 — Healthy Plant-based Diet and Periodontal Treatment · NA · recruiting
NCT06152614 — MIND Foods and Aerobic Training in Black Adults With HTN · NA · recruiting

Other Malaysia Palm Oil Board trials

Trials by the same sponsor.

NCT04156503 — Pilot Study-Quantitative Analysis of Positional Fatty Acids in Postprandial Chylomicron Triacylglycerol Using 13C NMR Sp · NA · completed
NCT03532763 — Anti-Inflammatory Effect of Tocotrienol Supplementation in Subjects With Moderately Elevated Inflammation · NA · unknown
NCT03256123 — The Effects of Biscuits Containing Red Palm Oil on School Children With Vitamin A Deficiency in West and East Malaysia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05791370 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Malaysia Palm Oil Board
Last refreshed: 30 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05791370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing